Absci Corporation
Americas
Vancouver
,
United States
Scaleup
FOUNDED
2011
HEADCOUNT
101-500
FUNDING
Public
Keywords:
AI/ML, synthetic_biology, therapeutics, antibodies, bacteria
BUSINESS
Combines AI with wet lab capabilities to design, validate, and optimize biologic drug candidates. Partners with pharma and biotech companies.
BIOTECH INVOLVEMENT
Core; generative-AI drug-creation company combining computational antibody and biologic design with an in-house wet lab. The SoluPro E. coli display platform expresses and screens billions of variants per week as training data for the AI models; the offering is IP and lead candidates rather than commercial biologic supply.
TECHNOLOGY PLATFORM
generative AI; synthetic biology; Integrated Drug Creation platform
PRIMARY PRODUCTS
ABS-201 for androgenetic alopecia; de novo antibodies